198 related articles for article (PubMed ID: 15293568)
1. Clinical relevance of survivin as a biomarker in neoplasms, especially in adult T-cell leukemias and acute leukemias.
Sugahara K; Uemura A; Harasawa H; Nagai H; Hirakata Y; Tomonaga M; Murata K; Sohda H; Nakagoe T; Shibasaki S; Yamada Y; Kamihira S
Int J Hematol; 2004 Jul; 80(1):52-8. PubMed ID: 15293568
[TBL] [Abstract][Full Text] [Related]
2. Survivin an important determinant for prognosis in adult T-cell leukemia: a novel biomarker in practical hemato-oncology.
Nakayama K; Kamihira S
Leuk Lymphoma; 2002 Dec; 43(12):2249-55. PubMed ID: 12613509
[TBL] [Abstract][Full Text] [Related]
3. Disturbed expression of the anti-apoptosis gene, survivin, and EPR-1 in hematological malignancies.
Shinozawa I; Inokuchi K; Wakabayashi I; Dan K
Leuk Res; 2000 Nov; 24(11):965-70. PubMed ID: 11086180
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia.
Nakagawa Y; Yamaguchi S; Hasegawa M; Nemoto T; Inoue M; Suzuki K; Hirokawa K; Kitagawa M
Leuk Res; 2004 May; 28(5):487-94. PubMed ID: 15068902
[TBL] [Abstract][Full Text] [Related]
5. Molecular detection of survivin expression, antiapoptotic gene, and other prognostic markers, how they are correlated and how it could be of prognostic value in chronic myeloid leukemia patient.
Zhara M; Mourad H; Farouk G; Elbatch M; Ezzat S; Sami W
Egypt J Immunol; 2007; 14(2):51-62. PubMed ID: 20306657
[TBL] [Abstract][Full Text] [Related]
6. Expression of the antiapoptotic gene survivin in chronic myeloid leukemia.
Badran A; Yoshida A; Wano Y; Imamura S; Kawai Y; Tsutani H; Inuzuka M; Ueda T
Anticancer Res; 2003; 23(1B):589-92. PubMed ID: 12680151
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of caspase cascade regulatory genes in adult T-cell leukaemia: survivin is an important determinant for prognosis.
Kamihira S; Yamada Y; Hirakata Y; Tomonaga M; Sugahara K; Hayashi T; Dateki N; Harasawa H; Nakayama K
Br J Haematol; 2001 Jul; 114(1):63-9. PubMed ID: 11472346
[TBL] [Abstract][Full Text] [Related]
8. Survivin expression in the progression of chronic myeloid leukemia: a sequential study in 16 patients.
Hernández-Boluda JC; Bellosillo B; Vela MC; Colomer D; Alvarez-Larrán A; Cervantes F
Leuk Lymphoma; 2005 May; 46(5):717-22. PubMed ID: 16019509
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitous expression of cytokines in diverse leukemias of lymphoid and myeloid lineage.
Kurzrock R; Kantarjian H; Wetzler M; Estrov Z; Estey E; Troutman-Worden K; Gutterman JU; Talpaz M
Exp Hematol; 1993 Jan; 21(1):80-5. PubMed ID: 8417962
[TBL] [Abstract][Full Text] [Related]
10. [The expression and clinical significance of survivin gene in leukemia].
Wang Y; Lin FR; Ren JH; Zhang JN; Chen J
Zhonghua Nei Ke Za Zhi; 2006 Aug; 45(8):628-30. PubMed ID: 17074144
[TBL] [Abstract][Full Text] [Related]
11. Expression of the antiapoptosis gene survivin in human leukemia.
Mori A; Wada H; Nishimura Y; Okamoto T; Takemoto Y; Kakishita E
Int J Hematol; 2002 Feb; 75(2):161-5. PubMed ID: 11939262
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro.
Kawasaki ES; Clark SS; Coyne MY; Smith SD; Champlin R; Witte ON; McCormick FP
Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5698-702. PubMed ID: 3165197
[TBL] [Abstract][Full Text] [Related]
13. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
Srivastava MD; Srivastava A; Srivastava BI
Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
[TBL] [Abstract][Full Text] [Related]
14. In vivo expression of survivin and its splice variant survivin-2B: impact on clinical outcome in acute myeloid leukemia.
Wagner M; Schmelz K; Wuchter C; Ludwig WD; Dörken B; Tamm I
Int J Cancer; 2006 Sep; 119(6):1291-7. PubMed ID: 16619249
[TBL] [Abstract][Full Text] [Related]
15. [Expression of antigen CD40 and survivin gene and their clinical implications in acute myeloid leukemia].
Zhu FB; Wang SY; Zhang YW
Zhonghua Nei Ke Za Zhi; 2004 Oct; 43(10):769-72. PubMed ID: 15631832
[TBL] [Abstract][Full Text] [Related]
16. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.
Yie SM; Luo B; Ye NY; Xie K; Ye SR
Clin Exp Metastasis; 2006; 23(5-6):279-89. PubMed ID: 17086357
[TBL] [Abstract][Full Text] [Related]
17. [Expression of survivin gene in NB4 cell line and cells of acute promyelocytic leukemia and its anti-apoptosis and clinical significance].
Xue J; Lin MF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):332-6. PubMed ID: 16638209
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of acute myeloid leukemia from B- and T-lineage acute lymphoid leukemias by real-time quantitative reverse transcription-PCR of lineage marker mRNAs.
Saussoy P; Vaerman JL; Straetmans N; Deneys V; Cornu G; Ferrant A; Latinne D
Clin Chem; 2004 Jul; 50(7):1165-73. PubMed ID: 15229149
[TBL] [Abstract][Full Text] [Related]
19. Survivin and aven: two distinct antiapoptotic signals in acute leukemias.
Paydas S; Tanriverdi K; Yavuz S; Disel U; Sahin B; Burgut R
Ann Oncol; 2003 Jul; 14(7):1045-50. PubMed ID: 12853345
[TBL] [Abstract][Full Text] [Related]
20. Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias.
Burger H; Nooter K; Zaman GJ; Sonneveld P; van Wingerden KE; Oostrum RG; Stoter G
Leukemia; 1994 Jun; 8(6):990-7. PubMed ID: 7911548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
